Plasma calprotectin in chronically dialyzed end-stage renal disease patients

Inflammation Research

Volumn 59, Issue 4, 2010, Pages 299-305

  Malĩcková, Karin ^a   Brodská, Helena ^a   Lachmanová, Jana ^a   Sulková, Sylvie Dusilová ^b   Janatková, Ivana ^a   Marečková, Helena ^a   Tesař, Vladimír ^a   Zima, Tomáš ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Calprotectin; End stage renal disease; Hemodialysis; Infection; Polymorphonuclear leukocytes

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CALGRANULIN; INTERLEUKIN 10; INTERLEUKIN 12; PROCALCITONIN; CALCITONIN; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PLASMA CLEARANCE; PROTEIN BLOOD LEVEL; BIOSYNTHESIS; BLOOD; CHRONIC KIDNEY FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

AGED; BETA 2-MICROGLOBULIN; C-REACTIVE PROTEIN; CALCITONIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; KIDNEY FAILURE, CHRONIC; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; MONOCYTES; PROTEIN PRECURSORS; RENAL DIALYSIS;

EID: 77953060137     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-0103-x     Document Type: Article

References (31)

1. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55(5):1899-1911
2. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, et al. Inflammation and cardiovascular events in individuals with and without chronic kidney disease. Kidney Int. 2008;73(12):1406-1412
3. Alexiewicz JM, Smogorzewski M, Fadda GZ, Massry SG. Impaired phagocytosis in dialysis patients: studies on mechanisms. Am J Nephrol. 1991;11(2):102-111
4. Bohler J, Donauer J, Birmelin M, Schollmeyer PJ, Hörl WH. Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins and leu-kotrienes. Nephrol Dial Transplant. 1993;8(12):1359-1365
5. Girndt M, Sester M, Sester U, Kaul H, Köhler H. Molecular aspects of T-and B-cell function in uremia. Kidney Int Suppl. 2001;78:S206-11.
6. Haag-Weber M, Horl WH. Dysfunction of polymorphonuclear leukocytes in uremia. Semin Nephrol. 1996;16(3):192-201.
7. Teruel JL, Marcen R, Ocaña J, Fernández-Lucas M, Rivera M, Tabernero G, et al. Clinical significance of C-reactive protein in patients on hemodialysis: a longitudinal study. Nephron Clin Pract. 2005;100(4):140-145
8. Lorton F, Veinberg F, Ielsch D, Deschenes G, Bensman A, Ulinski T. Procalcitonin serum levels in children undergoing chronic haemodialysis. Pediatr Nephrol. 2007;22:430-435
9. Steinbach G, Bolke E, Grunert A, Storck M, Orth K. Procalci-tonin in patients with acute and chronic renal insufficiency. Wien Klin Wochenschr. 2004;116:849-853
10. Kerkhoff C, Klempt M, Sorg C. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim Biophys Acta. 1998;1448(2):200-211
11. Maino VC, Picker LJ. Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry. 1998;34(5):207-215
12. Stenvinkel P. New insights on inflammation in chronic kidney disease-genetic and non-genetic factors. Nephrol Ther. 2006;2(3):111-119
13. Daniels I, Fletcher J, Haynes APOD. Role of p38 in the priming of human neutrophils by peritoneal dialysis effluent. Clin Diagn Lab Immunol. 1999;6(6):878-884
14. Dobos GJ, Traynor-Kaplan AE, Ward D, Schollmeyer PJ. Neu-trophil dysfunction in end-stage renal failure: reduced response to priming by C5a. Clin Investig. 1994;72(5):353-357
15. Haag-Weber M, Mai B, Horl WH. Effect of hemodialysis on intracellular calcium in human polymorphonuclear neutrophils. Miner Electrolyte Metab. 1992;18(2-5):151-155
16. Heidland A, Hörl WH, Heller N, Heine H, Neumann S, Heidbreder E. Proteolytic enzymes and catabolism: enhanced release of granulocyte proteinases in uremic intoxication and during hemodialysis. Kidney Int Suppl. 1983;16:S27-36.
17. Karpati I, Seres I, Mátyus J, Ben T, Paragh G, Varga Z, et al. Which parameters affect cytosolic free calcium in polymorpho-nuclear leukocytes of haemodialysis patients? Nephrol Dial Transplant. 2001;16(7):1409-1415
18. Hansch GM, Karnaoukhova S, Chang SH, Rus H, Nicolescu F, Deppisch R, et al. Activation of human neutrophils after contact with cellulose-based haemodialysis membranes: intracellular calcium signalling in single cells. Nephrol Dial Transplant. 1996;11(12):2453-2460
19. Hörl WH, Haag-Weber M, Mai B, Massry SG. Verapamil reverses abnormal [Ca2]i and carbohydrate metabolism of PMNL of dialysis patients. Kidney Int. 1995;47(6):1741-1745
20. Massry S, Smogorzewski M. Dysfunction of polymorphonuclear leukocytes in uremia: role of parathyroid hormone. Kidney Int Suppl. 2001;78:S195-6.
21. Ikemoto M, Tanaka T, Takai Y, Murayama H, Tanaka K, Fujita M, et al. New ELISA system for myeloid-related protein complex (MRP8/14) and its clinical significance as a sensitive marker for inflammatory responses associated with transplant rejection. Clin Chem. 2003;49(4):594-600.
22. Lugering N, Stoll R, Kucharzik T, Schmid KW, Rohlmann G, Burmeister G, et al. Immunohistochemical distribution and serum levels of the Ca(2)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion. 1995;56(5):406-414
23. Lugering N, Stoll R, Schmid KW, Kucharzik T, Stein H, Burmeister G, et al. The myeloic related protein MRP8/14 (27E10 antigen)-usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function. Eur J Clin Invest. 1995;25(9):659-664
24. Floris S, van der Goes A, Killestein J, Knol DL, Barkhof F, Polman CH. Monocyte activation and disease activity in multiple sclerosis. A longitudinal analysis of serum MRP8/14 levels. J Neuroimmunol. 2004;148(1-2):172-177
25. Terasaki F, Fujita M, Shimomura H, Tsukada B, Otsuka K, Otsuka K, et al. Enhanced expression of myeloid-related protein complex (MRP8/14) in macrophages and multinucleated giant cells in granulomas of patients with active cardiac sarcoidosis. Circ J. 2007;71(10):1545-1550
26. Striz I, Jaresová M, Lácha J, Sedlácek J, Vítko S. MRP 8/14 and procalcitonin serum levels in organ transplantations. Ann Transplant. 2001;6(2):6-9.
27. Bodlaj G, Berg J, Pichler R, Sailer T, Biesenbach G. Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters. J Nephrol. 2004;17(1):112-117
28. Ward RA. Phagocytic cell function as an index of biocompati-bility. Nephrol Dial Transplant. 1994;9:46-56.
29. Ward RA, McLeish KR. Oxidant stress in hemodialysis patients: what are the determining factors? Artif Organs. 2003;27:230-236
30. Blumberg A, Burgi W. Behaviour of beta 2-microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol. 1987;27(5):245-249
31. Kalocheretis P, Revela I, Spanou E, Drouzas A, Makriniotou I, Iatrou C. Strong correlation of B2-microglobulin (B2-m) with procalcitonin (PCT) in the serum of chronic hemodialysis patients: a role for infections in the dialysis-related amyloidosis? Ren Fail. 2008;30(3):261-265